Lightnews — Scholar-powered news

LifeArc @lifearc.bsky.social · 15h

Want to learn more about the translational development and manufacture of new gene therapies?

Innovation Hubs for Gene Therapies are now offering 3 new online training courses, created by NHS Blood and Transplant, @sheffielduni.bsky.social and @ucl.ac.uk

Learn more: https://t.ly/f-cc0

LifeArc @lifearc.bsky.social · 1d

We're supporting 5 projects as part of the @ukdri.ac.uk Translation Award Programme – providing researchers with the funds to help transform early-stage discovery into tests, therapies and treatments that can have a real clinical impact in neurodegenerative disease.

1 1

LifeArc @lifearc.bsky.social · 3d

What drives you to do your best at work?

Hear from our team about what keeps them motivated and makes them proud to be part of LifeArc.

If you're interested in being part of our team, see our careers page: https://www.lifearc.org/careers/

LifeArc @lifearc.bsky.social · 4d

The UK has an opportunity to transform the future for people living with rare diseases. Our COO, Karen Skinner, outlines some of the key recommendations from our recent report published with Genetic Alliance UK.

Read it here: https://www.lifearc.org/rd-report/

#ChangeTheRareFuture

LifeArc @lifearc.bsky.social · 5d

We are pleased to announce that George Orphanides has been appointed to the permanent position of Chief Scientific Officer, having joined LifeArc earlier this year to serve in this role in an interim capacity.

2

LifeArc @lifearc.bsky.social · 7d

As autumn colours begin to show, here are some of our iPSC-derived motor neurons with fiery red mitochondria to match the changing leaves.

This image is courtesy of our science team working on our induced pluripotent stem cell (iPSC) platform.

Photo credit: Finbar Gaffey

1 3

LifeArc @lifearc.bsky.social · 8d

That's a wrap on #GAMRIC2025! See today's highlights over on LinkedIn - t.ly/nr1sV

Thanks to all who attended and we look forward to seeing you again next year for #GAMRIC2026.

@carb-x.bsky.social @escmid.bsky.social @gardp.bsky.social

3 3

LifeArc @lifearc.bsky.social · 8d

The final day of #GAMRIC2025 is off to a great start, with the day's session on understanding the differences between patient and product journeys in low income, middle income and high income countries.

@carb-x.bsky.social @escmid.bsky.social @gardp.bsky.social

1 2

LifeArc @lifearc.bsky.social · 9d

The highlights of day 2 at #GAMRIC2025 are now live on our LinkedIn - t.ly/fgQ0i

@carb-x.bsky.social @escmid.bsky.social @gardp.bsky.social

#gamric2025 | LifeArc

A summary of day 2 at #GAMRIC2025 👇 • As one of the most drug-resistant infections, TB requires a radical shift from traditional drug R&D approaches. We heard how the TB Drug Accelerator (TBDA) is fe...

t.ly

2 3

LifeArc @lifearc.bsky.social · 9d

Diagnostics are a critical part of tackling #AMR. But how can developers create products that achieve widespread global use? Experts are taking the stage now at #GAMRIC2025 to discuss the gaps and possible innovations.

@carb-x.bsky.social @escmid.bsky.social @gardp.bsky.social

3

LifeArc @lifearc.bsky.social · 9d

Important discussions happening now on rare fungal pathogens, and antifungal R&D at #GAMRIC2025.

@carb-x.bsky.social @escmid.bsky.social @gardp.bsky.social

1 1

LifeArc @lifearc.bsky.social · 9d

Tuberculosis and its #AMR drug discovery challenges have the focus for today's second session at #GAMRIC2025.

Talks from Kelly Chibale, Steve Berthel, Dirk Schnappinger, Bree Aldridge, and Jansy Sarathy.

@carb-x.bsky.social @escmid.bsky.social @gardp.bsky.social

2 1

LifeArc @lifearc.bsky.social · 9d

Day 2 of #GAMRIC2025 is starting with discussions of lower respiratory tract infections, and how innovators can address challenges in diagnosis, clinical trials and therapeutics.

@carb-x.bsky.social @escmid.bsky.social @gardp.bsky.social

1 2

LifeArc @lifearc.bsky.social · 10d

A roundup of highlights from day one at #GAMRIC2025 is now live on our LinkedIn - www.linkedin.com/feed/update/...

@carb-x.bsky.social @escmid.bsky.social @gardp.bsky.social

#gamric2025 | LifeArc

Highlights from day one at #GAMRIC2025 👇 · David Paterson kicked off by outlining the scale of the global AMR crisis. He shared data showing that the burden of AMR caused by Gram-negative bacteria i...

www.linkedin.com

1 3

LifeArc @lifearc.bsky.social · 10d

A great way to round off day one at #GAMRIC2025 – listening to lightning talks from researchers who are showcasing their work in the poster session.

@carb-x.bsky.social @escmid.bsky.social @gardp.bsky.social escmid.bsky.social

2

LifeArc @lifearc.bsky.social · 10d

What are the challenges and potential interventions of STIs and #AMR? Can policy move the needle on AMR before 2029? These are the questions being asked in the afternoon sessions of #GAMRIC2025.

@carb-x.bsky.social @escmid.bsky.social @gardp.bsky.social dp.bsky.social

1 2

LifeArc @lifearc.bsky.social · 10d

In our second morning session of #GAMRIC2025, experts from around the world dive into the challenges and opportunities for how antimicrobial therapies can address the specific needs of newborns and children.

@carb-x.bsky.social @escmid.bsky.social @gardp.bsky.social

1 3

LifeArc @lifearc.bsky.social · 10d

This morning, Charlotte Watts, David Peterson, Sam Barrell and Marc Gitzinger took the stage at #GAMRIC2025 to discuss on the global #AMR crisis, and how organisations and researchers can come together to develop solutions.

@carb-x.bsky.social @escmid.bsky.social @gardp.bsky.social

1 1 5

LifeArc @lifearc.bsky.social · 10d

The inaugural Global AMR Innovators Conference (GAMRIC) has begun!

Stay tuned for updates and join the conversation here or on Bluesky using #GAMRIC2025.

@carb-x.bsky.social @escmid.bsky.social @gardp.bsky.social

1 3 5

LifeArc @lifearc.bsky.social · 11d

Help improve the diagnosis of chronic lung disease in primary care.

We're creating a target product profile (TPP) for a Simple Lung Test with @asthmaandlung.org.uk & @nihrtechevalhrc.bsky.social

If you work in diagnostics or lung health, take this survey to help refine our TPP:https://t.ly/vpHSv.

2 1

LifeArc @lifearc.bsky.social · 12d

Angela has faced one of every parent's worst fears – twice. She lost her daughter to cancer, then her son was diagnosed at 5.

Her story highlights the need for more and better targeted cancer therapies for children.

Hear her full story: https://youtu.be/Yl2xNhvHiZA

#ChildhoodCancerAwarenessMonth

Why we must do better for children with cancer | Angela’s story

YouTube video by LifeArc

youtu.be

LifeArc @lifearc.bsky.social · 14d

When it comes to medical research, lived experience is a vital form of expertise.

You can hear more from our COO, Karen Skinner, on why patient engagement is critical to effective drug development in a recent Keep It Science podcast episode.

🎧Listen now: https://t.ly/lTc_s

Insights Into the Rare Disease Research Landscape with @LifeArcOfficial and @SRFCURE

In this Keep It Science podcast episode, we talk to two experts building the research infrastructure of tomorrow: 🔹 Dr Karen Skinner, COO @LifeArcOfficial ...

t.ly

2

LifeArc @lifearc.bsky.social · 16d

A great opportunity!

LifeArc @lifearc.bsky.social · 16d

In April, we convened a summit to explore what needs to happen to bring CAR T-cell therapies to children with solid cancers.

For #ChildhoodCancerAwarenessMonth, our Head of Childhood Cancer, David Jenkinson, reflects on the importance of embracing innovation and adopting new approaches: t.ly/yi7oX

LifeArc @lifearc.bsky.social · 17d

Yesterday, our colleagues from across the UK gathered to reflect on the great work of the past few years, look ahead at exciting future plans, and have a great time together!

It was inspiring to unite over our shared sense of purpose to make a difference in the lives of patients.

1